What Changed
Price Move History
- Daily moves over 5%
- 0 65 sessions, April 20, 2026 to November 5, 2026
- Largest daily move
- -0.7% close of April 21, 2026
- 1-month change
- +0% closing prices, October 5, 2026 to November 5, 2026
Company Description
TRG Latin America Acquisitions (NASDAQ: TRGS) is classified in the shell companies industry within the Financial Services sector and carries a market capitalization of $259.4M.
TRGS has gained 0.0% over the past month. The last closing price was $9.97.
This page collects what Stock Titan holds for TRGS, including price data, latest news, SEC filings, and short interest trends.
Stock Performance
TRG Latin America Acquisitions (TRGS) closed at $9.97 on November 5, 2026. Over the past month, the price has gained 0.0%.
TRGS Metrics & Rankings
Price returns through November 5, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
TRG Latin America Acquisitions has 4 recent news articles. Key topics include IPO, offering. View all TRGS news →
SEC Filings
TRG Latin America Acquisitions has filed 4 recent SEC filings, including 2 Form 10-Q, 2 Form SCHEDULE 13G. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all TRGS SEC filings →
Short Interest History
Short interest in TRG Latin America Acquisitions (TRGS) currently stands at 4 shares, down 91.5% from the previous reporting period. Since April 2026, short interest has decreased by 96.7%.
Days to Cover History
Days to cover for TRG Latin America Acquisitions (TRGS) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.
TRGS Company Profile & Sector Positioning
TRG Latin America Acquisitions (TRGS) operates in the Shell Companies industry within the broader Financial Services sector and is listed on the NASDAQ.
Investors comparing TRGS often look at related companies in the same sector, including Dynamix Corporation III (DNMX), Xterax Corporation II (XTER), Catalyst Acquisition Corp. (CATL), Newbury Street II Acquisition Corp (NTWO), and Drugs Made In America Acquisition Corp. (DMAA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate TRGS's relative position within its industry.